Invention Grant
- Patent Title: Indole, indazole and indoline derivatives as CETP inhibitors
- Patent Title (中): 吲哚，吲唑和二氢吲哚衍生物作为CETP抑制剂
-
Application No.: US11197688Application Date: 2005-08-04
-
Publication No.: US07259183B2Publication Date: 2007-08-21
- Inventor: Aurelia Conte-Mayweg , Holger Kuehne , Thomas Luebbers , Cyrille Maugeais , Werner Mueller , Philippe Pflieger
- Applicant: Aurelia Conte-Mayweg , Holger Kuehne , Thomas Luebbers , Cyrille Maugeais , Werner Mueller , Philippe Pflieger
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- Priority: EP04103762 20040805
- Main IPC: A61K31/4045
- IPC: A61K31/4045 ; A61K31/416 ; C07D231/56 ; C07D209/08
Abstract:
The present invention relates to compounds of formula (I): wherein —X—Y—, R1 to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.
Public/Granted literature
- US20060030613A1 Indole, indazole and indoline derivatives as CETP inhibitors Public/Granted day:2006-02-09
Information query
IPC分类:
